Attend this conference on substance use disorders to hear the latest research and find guidance that enhances your care for patients.
Available Credits: 20.00 AMA PRA Category 1 Credit™ 20.00 Nursing Contact Hours 20.00 Social Workers 20.00 Participation 20.00 Psychologists CE Credit Register For This CourseAttend this conference on substance use disorders to hear the latest research and find guidance that enhances your care for patients.
Substance use disorders are complex and have a huge impact on patients, families and communities. They challenge even experienced health care professionals to stay current with evolving guidelines. And they are seen and treated across all professions, disciplines and practice settings. This includes primary care, psychiatry, social work, psychology, family practice, nursing and more.
That's why our agenda focuses on a broad update across the spectrum of substance use disorders. Sessions cover everything from neuroscience and developmental perspectives all the way through recovery-oriented systems of care. Our faculty share their experience as both clinical caregivers and research experts. They make time to answer questions and help you find solutions for complex conditions.
MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before January 4, 2021): $595.00
Early Bird Registration (on or before January 25, 2021): $695.00
Regular Registration (after January 25, 2021): $795.00
Other Professionals or Trainees
Super Early Bird Registration (on or before January 4, 2021): $495.00
Early Bird Registration (on or before January 25, 2021): $595.00
Regular Registration (after January 25, 2021): $695.00
Buprenorphine Waiver Training (Sunday, February 14, 2021): $50
This is a ticketed event, NO CME CREDIT
***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.***
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
A refund minus a $100.00 administrative fee will be issued for refund requests received by January 24, 2021. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
This program is intended for:
Our conference lets you engage dozens of renowned clinician-researchers, get your clinical questions answered, and translate enhanced knowledge into optimal patient care.
Here are some of the ways that participants plan to change their clinical practice as a result of attending our conference:
Substance Use Disorders: A Comprehensive Review and Update
February 14 – 17, 2021
PROGRAM AGENDA
SUNDAY, FEBRUARY 14, 2021
2:00 – 6:00 PM Buprenorphine (MAT) Waiver Training
Laura G. Kehoe, MD, MPH, FASAM
THIS IS A TICKETED EVENT, NO CME CREDIT
MONDAY, FEBRUARY 15, 2021
8:00 – 8:10 AM Welcome & Introduction
David H. Rubin, MD
MODULE TOPIC 1: Etiologies of Substance Use Disorder
8:10– 8:30 AM Neurobiology of Addiction
Timothy E. Wilens, MD
8:30 - 8:50 AM Genetics of Substance Use Disorders
Robert R. Althoff, MD, PhD
8:50 – 9:10 AM Evolutionary Theories of Substance Use
David H. Rubin, MD
MODULE TOPIC 2: General Principles and Care Delivery
9:10 – 9:30 AM Screening and Early Intervention
Christopher Shaw, NP
9:30 – 9:50 AM Treating Addiction as a Chronic Disease
Jessica Gray, MD
9:50 – 10:10 AM Harm Reduction
Dinah Applewhite, MD
10:10 – 10:30 AM Break
10:30 – 10: 50 AM Emergency Room Assessment of Addiction
Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP
10:50 – 11:10 AM The Impact of COVID on Treatment Access and Delivery
Eugene Lambert, MD
11:10 – 11: 30 AM Racial & Ethnic Disparities in Substance Use Disorders
Corrie Vilsaint, PhD
11:30 – 12:10 PM Panel Discussion
Moderator: David H. Rubin, MD
Panelists: Christopher Shaw, NP, Dinah Applewhite, MD, Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP, Eugene Lambert, MD, Corrie Vilsaint, PhD, Jessica Gray, MD
12:10 – 1:10 PM Lunch Break
MODULE TOPIC 3: Empirically Supported Psychosocial Treatment and Continuum of Care
1:10 – 1:30 PM Motivational Interviewing
John F. Kelly, PhD
1:30 – 1:50 PM CBT
John F. Kelly, PhD
1:50 – 2:10 PM CRAFT (Including Parents)
Martha Kane, PhD
2:10 – 2:30 PM Family Case Discussion
James McKowen, PhD
2:30 – 3:10 PM Panel Discussion
Moderator: Martha Kane, PhD
Panelists: John F. Kelly, PhD, James McKowen, PhD
3:10 – 3:30 PM Break
MODULE TOPIC 4: Recovery Support Services
3:30 – 3:50 PM Self-Help
John F. Kelly, PhD
3:50 – 4:10 PM Recovery Coaching
Martha Kane, PhD
4:10 – 4:30 PM E-Technologies
Brandon G. Bergman, PhD
4:30 – 5:10 PM Panel Discussion
Moderator: John F. Kelly, PhD
Panelists: Martha Kane, PhD, Brandon G. Bergman, PhD
5:10 PM Adjourn
TUESDAY, FEBRUARY 16, 2021
8:00 – 8:10 AM Introduction
Timothy E. Wilens, MD
MODULE TOPIC 5: Nicotine
8:10 – 8:30 AM Nicotine Use in Kids
Randi Schuster, MD
8:30 – 8:50 AM Vaping
Randi Schuster, MD
8:50 – 9:10 AM Nicotine and NRTs
Shamim H. Nejad, MD
9:10 – 9:50 AM Panel Discussion
Moderator: Timothy E. Wilens, MD
Panelists: Randi Schuster, MD, Shamim H. Nejad, MD
9:50 – 10:10 AM Break
MODULE TOPIC 6: Sedatives and Alcohol Use Disorders
10:10 – 10:30 AM Outpatient Management of Alcohol Use Disorder
Laura G. Kehoe, MD, MPH, FASAM
10:30 – 10:50 AM Inpatient Management of Alcohol Withdrawal Syndromes
Mladen Nisavic, MD
10:50 – 11:10 AM Sedatives and Hypnotics
Robert R. Althoff, MD, PhD
11:10 – 11:50 AM Panel Discussion
Moderator: Timothy E. Wilens, MD
Panelists: Laura G. Kehoe, MD, MPH, FASAM, Mladen Nisavic, MD, Robert R. Althoff, MD, PhD
11:50 – 12:50 PM Lunch Break
MODULE TOPIC 7: Stimulants
12:50 – 1:10 PM Methamphetamine
Timothy E. Wilens, MD
1:10 – 1:30 PM Cocaine, Rx Stimulants
Timothy E. Wilens, MD
1:30 – 2:10 PM Panel Discussion
Moderator: Jessica Gray, MD
Panelists: Timothy E. Wilens
2:10 – 2:30 PM Break
MODULE TOPIC 8: OPIOIDS
2:30 – 2:50 PM Overview of Opioid Use Disorder
Sarah Wakeman, MD
2:50 – 3:10 PM Buprenorphine 101
Laura G. Kehoe, MD, MPH, FASAM
3:10 – 3:30 PM Microdosing and Extended Release Buprenorphine
Evan Gale, MD
3:30 – 3:50 PM Pain
Jessica Gray, MD
3:50 – 4:10 PM Pregnancy
Davida Schiff, MD, MSc
4:10 – 4:50 PM Panel Discussion
Moderator: Laura G. Kehoe, MD, MPH, FASAM
Panelists: Sarah Wakeman, MD, Evan Gale, MD, Jessica Gray, MD, Davida Schiff, MD, MSc
4:50 PM Adjourn
WEDNESDAY, FEBRUARY 17, 2021
8:00 – 8:10 AM Introduction
David H. Rubin, MD
MODULE TOPIC 9: Marijuana
8:10 – 8:30 AM Cannabis Use & Use Disorders
Timothy E. Wilens, MD
8:30 – 8:50 AM Clinical Management
Robert R. Althoff, MD, PhD
8:50 – 9:30 AM Panel Discussion
Moderator: Timothy E. Wilens, MD
Panelists: Robert R. Althoff, MD, PhD
9:30 – 9:50 AM Break
MODULE TOPIC 10: Polysubstance Use
9:50 – 10:10 AM Fundamentals of Polysubstance Use
Timothy E. Wilens, MD
10:10 – 10:30 AM Polysubstance Use Cases
Laura G. Kehoe, MD, MPH, FASAM
10:30 – 11:10 AM Panel Discussion
Moderator: David H. Rubin, MD
Panelists: Timothy E. Wilens, MD,
Laura G. Kehoe, MD, MPH, FASAM
11:10 – 12:10 PM Lunch Break
MODULE TOPIC 11: Comorbidity
12:10 – 12:30 AM ADHD
Timothy E. Wilens, MD
12:30 – 12:50 PM Mood Disorders
Mladen Nisavic, MD
12:50 – 1:10 PM Anxiety Disorders
Shamim H. Nejad, MD
1:10 – 1:30 PM Trauma
Abigail Judge, PhD
1:30 – 2:10 PM Panel Discussion
Moderator: Timothy E. Wilens, MD
Panelists: Shamim H. Nejad, MD, Mladen Nisavic, MD, Abigail Judge, PhD
2:10 – 2:30 PM Break
MODULE TOPIC 12: Hallucinogens
2:30 – 2:50 PM Hallucinogens
Franklin King, MD
2:50 – 3:10 PM Psychedelics from Misuse to Therapeutics
Franklin King, MD
3:10 – 3:50 PM Panel Discussion
Moderator: David Rubin, MD
Panelists: Franklin King, MD
3:50 PM Adjourn
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this live activity for a maximum of 20.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 20.00 contact hours of nursing continuing education credit.
Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 20.00 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR.
Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 90149.
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists.
The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content. This offering meets the criteria for 20.00 Continuing Education (CE) credits per presentation for psychologists.
Policy on Faculty and Provider Disclosure
It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.
Resolution of Conflict of Interest (COI)
McLean Hospital has implemented a process to resolve COI for each CME activity. In order to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public, McLean Hospital has resolved the conflict by External Content Review.
Planner Disclosures
The MGH Psychiatry Academy adheres to all ACCME Essential Areas, Standards, and Policies. It is the Psychiatry Academy’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that the Psychiatry Academy may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of this activity) consumed by, or used on, patients:
Speakers & Planners:
Robert R. Althoff, MD, PhD
Investigator: NIMH, NIDA
Grand Funds (Medical Student Training Program Faculty Sponsor and PI) : Klingenstein Third Generation Foundation
Ownership Equity (Partner): WISER Systems, LLC
Jessica Gray, MD
Consultant: Massachusetts Consultation Service for Treatment of Addiction and Pain; Vermont Board of Medicine, NIDA (Salary Support)
Laura G. Kehoe, MD, MPH, FASAM
Consultant (Salary): Massachusetts Consultation Service for Treatment of Addiction and Pain; MAP Health Management Peer Recovery Support Services, Path CCM
Susan Sprich, PhD
Royalties (Co-Author): Oxford University Press
Royalties (Co-Edited Book): Springer
Honorarium: Association for Behavioral and Cognitive Therapies (ABCT)
Sarah Wakeman, MD
Consult Fee: Celero Systems
Royalties: UpToDate & Springer
Timothy E. Wilens, MD
Consulting Fees (Consultant): Ironshore, KemPharm, Otsuka, Vallon, US National Football League (ERM Associates), U.S. Minor/Major League Baseball, Arbor Pharmaceuticals
Royalties (Published Book: Straight Talk About Psychiatric Medications for Kids / Co-Edited Textbook - ADHD in Adults and Children): Guilford Press; Cambridge University Press
Royalties (Co-Owner of Before School Functioning Questionnaire): Ironshore
All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.